LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Home・Aandelen Lijst・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Gesloten

SectorGezondheidszorg

34.49 1.44

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

34.26

Max

34.56

Belangrijke statistieken
By Trading Economics
Inkomsten	-3.9M 46M
Verkoop	-17M 185M
K/W Sectorgemiddelde	13.042 53.54
EPS	0.779
Winstmarge	24.663
Werknemers	268
EBITDA	-10M 56M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+48.32% upside

Dividenden
By Dow Jones
Volgende Winsten	5 aug 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	222M 2B
Vorige openingsprijs	33.05
Vorige sluitingsprijs	34.49

Nieuwssentiment

By Acuity

50%

134 / 381 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

29.8 / N/A Steun & Weerstand

Harmony Biosciences Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 jun 2025, 23:56 UTC

Marktinformatie

Oil Rises Amid Geopolitical Tensions -- Market Talk

1 jun 2025, 23:47 UTC

Marktinformatie

Global Equities Roundup: Market Talk

1 jun 2025, 23:47 UTC

Marktinformatie

Nikkei May Decline as Tariff Uncertainty Continues -- Market Talk

1 jun 2025, 23:45 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

1 jun 2025, 23:44 UTC

Marktinformatie

Gold Rises After Trump Threatens to Double Steel, Aluminum Tariffs -- Market Talk

1 jun 2025, 23:39 UTC

Marktinformatie

Coles Bull Stands Firm Despite Temptation to Favor Woolworths -- Market Talk

31 mei 2025, 10:30 UTC

Top Nieuws

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 mei 2025, 06:30 UTC

Winsten

5 Things We've Learned From Retail Earnings -- Barrons.com

31 mei 2025, 04:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

30 mei 2025, 23:51 UTC

Acquisities, Fusies, Overnames

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 mei 2025, 21:30 UTC

Top Nieuws

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 mei 2025, 21:15 UTC

Top Nieuws

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 mei 2025, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

30 mei 2025, 20:44 UTC

Acquisities, Fusies, Overnames

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 mei 2025, 20:24 UTC

Top Nieuws

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 mei 2025, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

30 mei 2025, 19:44 UTC

Marktinformatie

Gold Breaks 4-Month Winning Streak -- Market Talk

30 mei 2025, 19:38 UTC

Marktinformatie

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 mei 2025, 19:29 UTC

Winsten

Acquisities, Fusies, Overnames

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 mei 2025, 19:14 UTC

Marktinformatie

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 mei 2025, 19:05 UTC

Marktinformatie

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 mei 2025, 18:51 UTC

Marktinformatie

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 mei 2025, 18:37 UTC

Marktinformatie

Winsten

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 mei 2025, 18:04 UTC

Top Nieuws

S&P 500 Falls After More Trump-China Friction -- WSJ

30 mei 2025, 17:47 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

30 mei 2025, 17:47 UTC

Marktinformatie

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 mei 2025, 17:40 UTC

Acquisities, Fusies, Overnames

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 mei 2025, 17:38 UTC

Marktinformatie

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 mei 2025, 17:31 UTC

Marktinformatie

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 mei 2025, 17:14 UTC

Top Nieuws

American Consumers Are Still Gloomy on the Economy -- 3rd Update

Peer Vergelijking

Prijswijziging

Harmony Biosciences Holdings Inc Prognose

Koersdoel

By TipRanks

48.32% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 51.17 USD 48.32%

Hoogste 70 USD

Laagste 31 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Harmony Biosciences Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Harmony Biosciences Holdings Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

29.8 / N/ASteun & Weerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

134 / 381 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.